This inventor holds 7 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Zenyaku Kogyo Kabushiki Kaisha, Juntendo University School of Medicine, Denka Seiken Co., Ltd.. Active years: 2000-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Tokyo, JP (2000 - 2012)
- Bunkyo-ku, JP (2017)
Company Filing History:
3 out of 41 
2 out of 2 
1 out of 61 
Years Active: 2000-2017
Title: Keiichi Hiramatsu: Innovator in Antibody Development
Introduction
Keiichi Hiramatsu is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of immunology, particularly in the development of antibodies for therapeutic applications. With a total of 7 patents, Hiramatsu's work addresses critical health issues, including staphylococcal infections.
Latest Patents
Hiramatsu's latest patents focus on providing an anti-antibody that has preventive or therapeutic effects on staphylococcal infections. The invention includes a method for manufacturing this antibody, as well as a composition, product, and drug containing it. The antibody is derived from deacetylated materials used for immunization. Another significant patent involves a toxin detection method, which provides an antibody against the Panton-Valentine leukocidin toxin. This method includes a kit for detecting the toxin and a pharmaceutical composition for treating infections caused by this toxin.
Career Highlights
Throughout his career, Keiichi Hiramatsu has worked with notable organizations, including Zenyaku Kogyo Kabushiki Kaisha and Juntendo University School of Medicine. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Hiramatsu has collaborated with esteemed colleagues such as Seiichiro Kawashima and Hideaki Hanaki. These partnerships have further enriched his research and development efforts in the field of immunology.
Conclusion
Keiichi Hiramatsu is a distinguished inventor whose work in antibody development has the potential to significantly impact the treatment of infections. His innovative approaches and collaborations continue to advance the field of immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile